- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Local and reginonal irradiation and brief reduced-dose chemotherapy for non-Hodgkin's lymphoma (stage IE,IIE)of Waldeyer's ring with adult diseases.
-
- OGUCHI Masahiko
- Department of Radiology, School of Medicine Shinshu University
-
- SHIKAMA Naoto
- Department of Radiology, School of Medicine Shinshu University
-
- GOMI Koutarou
- Department of Radiology, School of Medicine Shinshu University
-
- IZUNO Itaru
- Department of Radiology, School of Medicine Shinshu University
-
- TAKEI Kazuyoshi
- Department of Radiology, School of Medicine Shinshu University
-
- SASAKI Shigeru
- Department of Radiology, School of Medicine Shinshu University
-
- KIYONO Kunihiro
- Department of Radiology, School of Medicine Shinshu University
Bibliographic Information
- Other Title
-
- ワルダイヤ輪初発非ホジキンリンパ腫(Stage IE,IIE)の治療 成人病合併例に対する局所および隣接リンパ節領域照射と短期減量化学療法の有用性
- 成人病合併例に対する局所および隣接リンパ節領域照射と短期減量化学療法の有用性
Search this article
Description
Purpose: Usually, the middle-aged patients with non-Hodgkin's lymphoma and concomitant other adult diseases can not be tolerable for intensive chemotherapy. Then we introduced a new regimen composed of radiation for local and sorrounding lymph node areas, and brief reduced-dose chemotherapy into treatment for such patients.<br>Subjects and Methods: Thirth-eight patients with Stage IE or Stage IIE non-Hodgkin's lymphoma of the Waldeyer's ring were a core of this study. Histopathologically they were diagnosed as diffuse intermediate grade. In addi-tion, they suffered from other adult diseases such as cardiovascular diseases, cereblovascular disorders, diabetus melitus, chronic liver diseases, etc. They were treated by the combined modality composed of reduced-dose chemo-therapy (70%-ACOP: 2 cycles or 70%-MACOP-B: 8 weeks) and regional lymph node irradiation (30Gy) puls boost irradiation (10Gy) to inolved area (total 40Gy).<br>Results: No relapses were observed in the radiation field, the 5-year disease-free survival rate and cause-specific survival rate for all patients were 85.7% and 91.4%, respectively. There were no differences of the 5-year disease-free survival rate between stage IE and IIE, among the pathological subtypes, among the complications and etc.<br>Conclusion: The regimen composed of regional lymph node irradiation (30Gy) puls boost irradiation (10Gy) to involved area (total 40Gy) and reduced-dose chemotherapy (70%-dose ACOP, 70%-dose MACOP-B) is a safe and useful approach to treatment for diffuse intermediate grade of B cell lymphoma in middle-aged patients having other adult diseases.
Journal
-
- Japanese jornal of Head and Neck Cancer
-
Japanese jornal of Head and Neck Cancer 23 (1), 28-33, 1997
Japan Society for Head and Neck Cancer
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204730363008
-
- NII Article ID
- 130004063254
- 10012232098
-
- NII Book ID
- AN00165234
-
- ISSN
- 18839878
- 09114335
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed